These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7942266)

  • 1. Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs.
    Cory AH; Cory JG
    Adv Enzyme Regul; 1994; 34():1-12. PubMed ID: 7942266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
    Cory AH; Samano V; Robins MJ; Cory JG
    Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.
    Cory AH; Shibley IA; Chalovich JM; Cory JG
    J Biol Chem; 1993 Jan; 268(1):405-9. PubMed ID: 8380161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosine.
    Cory JG; Nelson TO; Somerville L; Cory AH
    Adv Enzyme Regul; 1997; 37():3-16. PubMed ID: 9381977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides.
    Sarup JC; Fridland A
    Biochemistry; 1987 Jan; 26(2):590-7. PubMed ID: 3030413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J; De Clercq E
    Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
    Cory AH; Hertel LW; Kroin JS; Cory JG
    Oncol Res; 1993; 5(2):59-63. PubMed ID: 8364254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of 2,6-diaminopurine and 2,6-diaminopurine-2'-deoxyriboside to antitumor agents.
    Weckbecker G; Cory JG
    Adv Enzyme Regul; 1989; 28():125-44. PubMed ID: 2624171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
    Zhu C; Johansson M; Permert J; Karlsson A
    Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine kinase deficiency in tritiated deoxyadenosine-resistant mouse S49 lymphoma cell lines.
    Sastry KJ; Huang C; Chan TS
    Biochem Genet; 1987 Dec; 25(11-12):765-77. PubMed ID: 2835956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct sites for deoxyguanosine and deoxyadenosine phosphorylation on a monomeric kinase from Lactobacillus acidophilus.
    Chakravarty R; Ikeda S; Ives DH
    Biochemistry; 1984 Dec; 23(25):6235-40. PubMed ID: 6098313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines.
    Zhu C; Johansson M; Permert J; Karlsson A
    J Biol Chem; 1998 Jun; 273(24):14707-11. PubMed ID: 9614068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential incorporation of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosylguanine into nuclear and mitochondrial DNA.
    Zhu C; Johansson M; Karlsson A
    FEBS Lett; 2000 Jun; 474(2-3):129-32. PubMed ID: 10838071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases.
    Johansson NG; Eriksson S
    Acta Biochim Pol; 1996; 43(1):143-60. PubMed ID: 8790720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.
    Fyrberg A; Albertioni F; Lotfi K
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
    Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
    Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants.
    Solaroli N; Johansson M; Balzarini J; Karlsson A
    Gene Ther; 2007 Jan; 14(1):86-92. PubMed ID: 16885999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoisomeric selectivity of human deoxyribonucleoside kinases.
    Wang J; Choudhury D; Chattopadhyaya J; Eriksson S
    Biochemistry; 1999 Dec; 38(51):16993-9. PubMed ID: 10606535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.